Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by BoracayGuyon Apr 05, 2021 2:13pm
157 Views
Post# 32938045

RE:RE:RE:WHY IS THIS STOCK NOT FLYING HIGH???

RE:RE:RE:WHY IS THIS STOCK NOT FLYING HIGH???
Warrant, 
 
1. you can not create and market a product until after you receive a license in a country.
2. Voy has never been financed to move forward with sales and marketing, they need staff for marketing and sales, Management was off salary for most of 2020, and with covid it is amazing that these guys did not go broke.
3. They have to test their new products, using the equipment at AVL. They need to spend months testing stability, freeze thaw, shelf life, ext.
4. before they go to market they need to test on patients to ensure their product is high quality and get endorsements from clinics.
 
This company has just broke through their financial barriers, it is nothing  but up from here. In 6 months cash flow should begin, if not sooner.

Also a PEA  and Pre-feasibilty are pending in coming months. What values is Franfes Creek?$0.80/share?, $1/share, $3/share?

 Its an absolutely no brainier getting into this stock. Once they begin sales, what multiples do pharma companies trade at? Its exciting times for (us) VM holders.  
<< Previous
Bullboard Posts
Next >>